Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 15, 2023 4:30 P.M.
Form: S-3
CIK: 0001693011
Company Name: Inozyme Pharma, Inc.
File Number: 333-275364